Kainic acid induces expression of caveolin-1 in activated microglia in rat brain by Takeuchi, Shigeko et al.
FOLIA HISTOCHEMICA
ET CYTOBIOLOGICA
Vol. 51, No. 1, 2013
pp. 25–30
©Polish Society for Histochemistry and Cytochemistry




Correspondence address: O. Yasuhara
University of Shiga Prefecture School of Human Nursing
2500 Hassaka-cho, Hikone 522–8533, Japan;
tel: +81 749 28 86 45;
fax: +81 749 28 95 13;
e-mail: yasuhara.o@nurse.usp.ac.jp
Kainic acid induces expression of caveolin-1
in activated microglia in rat brain
Shigeko Takeuchi1, Wakoto Matsuda2, Ikuo Tooyama1, Osamu Yasuhara2, 3
1Molecular Neuroscience Research Center, Shiga University of Medical Science, Otsu, Japan
2Department of Anatomy, Shiga University of Medical Science, Otsu, Japan
3University of Shiga Prefecture School of Human Nursing, Hikone, Japan
Abstract: Caveolin-1, a major constituent of caveolae, has been implicated in endocytosis, signal transduction
and cholesterol transport in a wide variety of cells. In the present study, the expression of caveolin-1 was exam-
ined by immunohistochemistry in rat brain with or without systemic injection of kainic acid (KA). Caveolin-1
immunoreactivity was observed in capillary walls in brains of control rats. From one to seven days after KA
injection, caveolin-1 immunoreactivity appeared in activated microglia in the cerebral cortex, hippocampus and
other brain regions. The strongest immunoreactivity of microglia was seen after 3 days after KA administration.
The expression of caveolin-1 was confirmed by RT-PCR and Western blot analysis, respectively. The induction
of caveolin-1 expression in microglia activated in response to kainic acid administration suggests its possible role
in a modulation of inflammation. (Folia Histochemica et Cytobiologica 2013, Vol. 51, No. 1, 25–30)
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Introduction
Caveolin-1 is the major protein component of caveo-
lae that are cholesterol- and sphingolipid-enriched mi-
crodomains of the plasma membrane [1]. Because
caveolae are believed to be involved in two-way com-
munication and exchange of molecules between the
cell and extracellular environment, caveolin-1 has
been implicated in multiple cellular functions includ-
ing endocytosis, signal transduction and cholesterol
transport [2]. In addition to caveolae, caveolin-1 was
shown to be present in non-caveolar scaffold domains
on the plasma membrane [3] and at many other in-
tracellular locations [2]. Probably caveolin-1 plays
important multiple biological roles in a heterogeneous
cellular microenvironments.
In the brain, caveolin-1 has been reportedly found
in endothelial cells and astrocytes [4]. The expression
of caveolin-1 was also demonstrated in many types of
cells in culture, including astrocytes [5], differentiat-
ing PC12 cells, dorsal root ganglion neurons [6], and
oligodendrocytes [7]. Furthermore, injuries to the
spinal cord caused an increase in phosphorylation of
caveolin-1 in macrophages and microglia [8, 9]. These
results suggest that virtually all types of cells in the
nervous system are potentially capable of producing
caveolin-1.
In rodents, injection of kainic acid (KA) results in
recurrent seizures, behavioral changes, and subse-
quent degeneration of selective populations of neu-
rons in the brain, showing characteristics similar to
human temporal lobe epilepsy [10]. The hippocam-
pus is particularly vulnerable to KA-induced neuro-
toxicity, where the pathological changes are charac-
terized by pyramidal cell loss associated with glial
activation, mossy fiber synaptic reorganization, and
increased neurogenesis of dentate granule cells [10–12].
Thus, KA administration in rodents has widely been
used as a model to elucidate the mechanisms of neuro-
toxicity of excitatory neurotransmitters. Bu et al. [13]
26 S. Takeuchi et al.
©Polish Society for Histochemistry and Cytochemistry
Folia Histochem Cytobiol. 2013
10.5603/FHC.2013.004
www.fhc.viamedica.pl
demonstrated that KA and other glutamate receptor
agonists induce expression of caveolin-1 in a concen-
tration-dependent manner in cultured primary hip-
pocampal neurons of rats. This observation strongly
suggests a role of caveolin-1 in KA-induced neuronal
damage. To clarify the involvement of caveolin-1 in
KA-induced excitotoxicity, we examined in the present
study expression of caveolin-1 and its mRNA in rat
brain after KA administration, by RT-PCR, Western
blot analysis and immunohistochemistry.
Material and methods
Animals. Male Wistar rats (Clea Japan Inc., Tokyo, Japan),
weighing 250–300 g, were used. The rats were handled in
compliance with the principles of the National Institute of
Health Guide for the Care and Use of Laboratory Animals
(NIH Publications No. 80–23, revised 1986). All efforts were
made to minimize both the number of animals used and
any suffering that they might experience. The rats received
a single intraperitoneal (i.p.) injection of KA (Sigma, St.
Louis, MO, USA; 12 mg/kg dissolved in physiological
saline). Only the rats which showed generalized seizures
(tonic-clonic convulsions) were used in this study.
Immunohistochemistry. Caveolin-1 immunohistochemistry
was performed using the rats with survival periods of one,
three and seven days after KA injection (n = 3 in each
group). The rats injected with physiological saline served as
the control group (1, 3, and 7 days post-injection; n = 2 in
each group). Each animal was perfused through the ascend-
ing aorta with 10 mM phosphate-buffered saline (PBS, pH
7.4), followed by a fixative of 4% paraformaldehyde in 0.1
M phosphate buffer (PB, pH 7.4). The brains were removed
from the skull and postfixed overnight in a fixative of 4%
paraformaldehyde in 0.1 M PB at 4°C. After cryoprotec-
tion with 0.1 M PB containing 15% sucrose, 20 µm-thick sec-
tions were cut in a cryostat and stored in 0.1 M PBS con-
taining 0.3% Triton X-100 (PBST) until used.
The sections, in a free-floating state, were incubated
overnight with a rabbit polyclonal antibody against caveo-
lin-1 (N-20; Santa Cruz Biotechnology, Santa Cruz, CA,
USA; diluted 1: 4000) at 4°C, for 2 h with biotinylated anti-
rabbit IgG (Vector Labs, Burlingame, CA, USA; diluted 1:
1000) at room temperature, and for 1 h with the avidin-
biotinylated peroxidase complex (ABC Elite; Vector; dilut-
ed 1: 2000) at room temperature. Dilution of the reagents
and washing of sections between each step were done with
PBST. Color was developed by reacting the sections for 10
min with a mixture containing 0.02% 3,3'-diaminobenzidine,
0.0045% H2O2 and 0.3% nickel ammonium sulfate in 50 mM
Tris-HCl buffer (pH 7.6). The stained sections were air-
dried, washed in tap water, dried through a graded series of
alcohol, cleared with xylene, and coverslipped with Entel-
lan (Merck, Darmstadt, Germany). For immunohistochem-
ical controls, the caveolin-1 antibody which had been pre-
incubated overnight with the blocking peptide of caveolin-
1 (sc-894P, Santa Cruz Biotechnology, Santa Cruz, CA,
USA) was applied to immunohistochemical procedures. No
positive staining was observed in these control studies.
To characterize caveolin-1-positive cells, sections from
a rat 3 days after KA injection were doubly stained for ca-
veolin-1 as described above, and one of the following three
marker proteins. They were NeuN for neurons (MAB377,
mouse monoclonal; Chemicon, Temecula, CA, USA; dilut-
ed 1:1000), glial fibrillary acidic protein (GFAP) for astro-
cytes (GF12.24, mouse monoclonal; Progen, Heidelberg,
Germany; 1:10), and CD11b for activated microglia (OX42,
mouse monoclonal; Serotec, Raleigh, NC, USA; diluted
1:500). After overnight-incubation in a mixture of primary
antibodies, the sections were covered for 2 h with a mixture
of Alexa Fluor 488-conjugated anti-rabbit IgG (for caveo-
lin-1) and Alexa Fluor 594-conjugated anti-mouse IgG (for
NeuN, GFAP or CD11b) (all made in goat; Molecular
Probes Inc., Eugene, OR, USA; 1:1000) at room tempera-
ture. After washing, the mounted sections were analyzed
with a Zeiss LSM 510 confocal laser scanning microscope
(Carl Zeiss, Thornwood, NY) equipped with an argon laser
(458/488/514 nm), and a green helium/neon laser (543 nm).
Single optical slice images were taken using 40 × LD Ach-
roplan air interface objective lens at a z-axis step of 0.6 µm
depth.
RT-PCR. After perfusion with 10 mM PBS, brains were re-
moved from a saline-injected control rat and a KA-injected
rat 3 days post-injection. Total RNA was extracted from
fresh tissues of right cerebral cortex and hippocampus us-
ing the acid guanidium thiocyanate-phenol method. Five
mg of each total RNA was reversely transcribed for the syn-
thesis of the first strand cDNA using 500 pmol of oligo-
dT12-18 (Amersham Biosciences Corp., Arlington Heights,
IL) and 200 units of SuperScript II (Gibco BRL, Gaithers-
burg, MD).
PCR was performed in the GeneAmp PCR System 2400
(Perkin Elmer, Foster City, CA) using a primer pair specific
to rat caveolin-1 cDNA. The exact nucleotide sequences of
the primers were; 5'-CTACAAGCCCAACAACAAGGC-3'
(5'-sense primer), and 5'-AGGAAGCTCTTGATGCACG-
GT-3' (3'-antisense primer) (GenBank no. AF439778). For
a control, PCR for b-actin gene was done in a separate tube.
The sequences of the primers for rat b-actin were: 5'-TG-
GTGGGTATGGGTCAGAAGGACTC-3' (5'-sense primer),
and 5'-CATGGCTGGGGTGTTGAAGGTCTCA-3'
(3'-antisense primer). The expected sizes of the PCR prod-
ucts were 342 base pair (bp) for caveolin-1 and 265 bp for
b-actin, respectively.
Each 25 µl reaction mixture consisted of 2 ng/µl of the
template cDNA, 0.8 µM of each of the primers, 0.2 mM of
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each of 4 deoxynucleotide triphosphates and 0.25 units of
AmpliTaq Gold polymerase (Perkin Elmer) in 1xPCR buffer
(Perkin Elmer). After preincubation for 10 min at 95°C, the
amplification program was performed for 34 cycles with de-
naturation for 0.5 min at 95°C, annealing for 0.5 min at 64°C,
and extension for 1.5 min at 72°C. The PCR products were
electrophoresed on a 3% agarose gel and stained with ethid-
ium bromide. After dissecting out the expected bands from
the gel, the target PCR product was eluted, and DNA was
cloned using a TA cloning system (Invitrogen Corp., Carls-
bad, CA), followed by sequencing using the ABI-PRISM cy-
cle sequencing kit and 310 DNA sequencer (Perkin Elmer).
Western blot analysis. After perfusion with 10 mM PBS,
tissues of right cerebral cortex and hippocampus were ob-
tained from both a saline-injected control rat and a rat
3 days after KA injection. They were homogenized in 10 vo-
lumes of ice-cold 20 mM Tris-HCl (pH 7.5), 0.15 M NaCl,
1% Triton X-100, and 60 mM octyl-glucoside, under the
presence of protease inhibitor cocktail tablets, Complete
Mini (Roche Diagnostics, Mannheim, Germany; one tab-
let/10 mL). The homogenates were centrifuged at 14000 g
for 20 min at 4°C. About 25 µg of the crude extracted pro-
tein and Prestained Precision Protein Standards (Bio-Rad,
Hercules, CA, USA) were electrophoresed on a 10% sodi-
um dodecyl sulfate (SDS)-polyacrylamide gel under a re-
ducing condition, and then transferred to a polyvinylidene
difluoride membrane (Immobilon-P; Millipore, Tokyo, Ja-
pan). The membrane was incubated overnight with the rab-
bit antibody against caveolin-1 (N20; Santa Cruz Biotech-
nology; diluted 1:2 000) in 25 mM TBS containing 0.1%
Tween 20 (TBST) at 4°C, and then for 2 h with a peroxi-
dase-coupled anti-rabbit IgG Fab’ fragment (Histofine;
Nichirei Corporation, Tokyo, Japan; diluted 1:100). The
peroxidase labeling was detected by chemiluminescence
using the SuperSignal West Pico Chemiluminescent Sub-
strate (Pierce, Rockford, IL, USA).
Results
In saline-injected control rats, capillary walls were
positively stained for caveolin-1 in many brain regions
including the cerebral cortex (Figure 1A) and hip-
pocampus (Figure 1B). One day after KA adminis-
tration, caveolin-1-positive cells appeared in the brain
including the cerebral cortex and hippocampus. Three
days after KA injection, the number of positive cells
increased in the cerebral cortex (Figure 1C). Many
Figure 1. Immunostaining for caveolin-1 in the parietal cortex (A, C, E) and the CA3 area of the hippocampus (B, D, F)
from control and KA-treated rats. (A, B) A saline-injected control rat, showing positive capillary staining. (C, D) A rat
3 days after KA injection. Intensely stained cells appear in the cortex and are accumulated in the CA3. Arrows in C show
positive cells with pyramidal morphology. (E, F) A rat 7 days after KA injection. Weakly stained positive cells are present
in the cortex, but intensely stained cells are aggregated in the CA3. Bar = 50 mm
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immunoreactive (ir) positive cells had small, round
to ovoid cell bodies with several processes, while some
positive cells showed pyramidal profiles (Figure 1C).
In the hippocampus, particularly in the CA3 area,
a dense accumulation of ir-positive cells was observed
(Figure 1D). Similar aggregations of immunoreactive
cells were also detected in the thalamus and entorhi-
nal cortex.
To better characterize ir-positive cells, brain sec-
tions of the rats 3 days after KA injection were dou-
bly stained for caveolin-1 and one of the selected three
markers of various brain cell populations. As shown
in Figure 2, caveolin-1 immunoreactivity was observed
in virtually all CD11b-positive (OX42-labelled) mi-
croglia and only a few GFAP-positive astrocytes, but
not in NeuN-positive neurons. Thus, the major pop-
ulation of caveolin-1-positive cells was found to con-
sist of activated microglia.
Seven days after KA-injection, the number and
staining intensity of positive microglia decreased in
the cerebral cortex (Figure 1E). Only a few positive
cells showed morphology of activated microglia. Pos-
itive microglial aggregates were found in the regions
vulnerable to the toxic effects of KA, such as the CA3
area of the hippocampus (Figure 1F), some thalamic
nuclei, amygdala and entorhinal cortex.
Figure 3A shows expression of caveolin-1 mRNA
analyzed by RT-PCR. As shown, the amplification
Figure 2. Confocal fluorescent images of the cerebral cortex doubly stained for caveolin-1 and one of the cell marker
antigens. (A–C) Caveolin-1-positive cells (green; A), NeuN-positive neurons (red; B), and a composite image of A and B
(C), showing no overlap of these two types of cell. (D–F) Caveolin-1-positive cells (green; D), GFAP-positive astrocytes
(red; E), and a composite image of D and E (F), showing only a partial overlap of these two types of cell. (G–I) Caveolin-
1-positive cells (green; G), OX42-labelled microglia (red; H), and a composite image of G and H (I), showing an overlap
of caveolin-1-positive cells and OX42-labelled microglia (yellow). Bar = 50 mm
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product for the caveolin-1 gene was detected with the
expected size (342 bp) in the cerebral cortex and hip-
pocampus of both saline-injected and KA-treated rats.
The nucleotide sequence analysis confirmed the iden-
tity of the PCR product with the caveolin-1 gene frag-
ment. No mutation was found within the nucleotide
sequence of analyzed fragments. In Western blot anal-
ysis, the caveolin-1 antibody revealed a positive band
of about 22 kDa in the cerebral cortex and hippoc-
ampus of both saline-injected and KA-treated rats
(Figure 3B).
Discussion
In the present study, two major types of cells are rec-
ognized to express caveolin-1 in rat brain. First, cave-
olin-1 immunoreactivity was present in capillary en-
dothelial cells in vehicle-injected control rats. Second,
caveolin-1-positive microglia were widely distributed
in the brain areas including the cerebral cortex and
hippocampus from 1 day to 3 days after injection.
Seven days post-injection, positive microglia were
confined to such vulnerable areas as the hippocam-
pus, thalamus and entorhinal cortex. The present
study demonstrates for the first time that the expres-
sion of caveolin-1 is induced in activated microglia in
rat brain after systemic treatment with KA. The ex-
Figure 3. RT-PCR and Western blot analysis for caveolin-1.
Lanes 1–4: right cerebral cortex (lane 1) and right hippo-
campus (lane 2) from a saline-injected rat, and right
cerebral cortex (lane 3) and right hippocampus (lane 4)
from a rat 3 days after KA injection. (A) RT-PCR for
caveolin-1 and b-actin mRNA. The products with the
expected sizes (342 bp for caveolin-1, and 265 bp for
b-actin, respectively) are detectable. The locations of the
molecular size markers are indicated on the left. (B)
Western blot analysis, showing the positive bands at about
22 kDa in all samples. The molecular weights of the size
markers are indicated on the left
pression of caveolin-1 and its mRNA in the brain of
KA-treated rats were confirmed by Western blot anal-
ysis and RT-PCR, respectively, though the changes
in their expression levels should be determined by
future quantitative analyses.
Microglia and macrophages are the cells of the
mononuclear phagocyte lineage originating from
monocytes. Although the expression of caveolin-1 in
immune cells has long been debated [14], a body of
evidence indicates that macrophages actually express
caveolin-1 in pathological conditions [15]. In addition,
it is reported that the expression of caveolin-1 gene is
up-regulated in monocytes after activation by adhe-
sion to endothelial cells [16]. The present study pro-
vides additional evidence indicating that caveolin-1
plays roles in tissue injuries through cells of the mono-
nuclear phagocytic system. Because CD11b antigen
is expressed by two groups of morphologically indis-
tinguishable phagocytic cells, resident brain micro-
glia and infiltrating peripheral macrophages [17], the
exact origin of the caveolin-1-positive brain cells re-
mains to be determined. Although a previous in vitro
study has shown that cultured primary hippocampal
neurons from rats express caveolin-1 after excitotox-
ic treatment [13], the present study failed to show any
caveolin-1-positive neurons in KA-treated rat brains.
The precise functional role of caveolin-1 in acti-
vated microglia is unclear. It is probable that caveo-
lin-1 is involved in lipid metabolism in microglia [14].
More importantly, it is suggested that caveolin-1 is a
potent modulator of inflammation. Bucci et al. [18]
showed a role of caveolin-1 in suppression of inflam-
mation, by using the scaffoling domain of caveolin-1
to inhibit edema formation and vascular leakage in
rats. Such anti-inflammatory effects of caveolin-1 have
partly been ascribed more directly to the action of
caveolin-1 in macrophages. For example, caveolin-1
deficient macrophages display impaired phagocyto-
sis [19]. Wang et al. [20] demonstrated that caveolin-
1 acts as a potent immunomodulatory effecter mole-
cule in murine alveolar and peritoneal macrophages.
They showed that caveolin-1 has a protective role for
inflammation by suppression of pro-inflammatory cy-
tokine production (TNF-a and IL-6) and augmentation
of anti-inflammatory cytokine production (IL-10)
[20]. Thus, it is tempting to speculate that caveolin-1
in activated microglia participates in modulation
of inflammation in the brain in response to excito-
toxic insults.
In summary, we have demonstrated for the first
time that KA administration induces the expression
of caveolin-1 in activated microglia in rat brain. The
results suggest an immunomodulatory role of caveo-
lin-1 in KA-induced brain damage. Because activat-
A Caveolin-1
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ed microglia are known to act both neurotoxic and
neuroprotective effects [21], it is unclear whether the
action of microglial caveolin-1 is toxic or protective
to neurons. Another question is whether caveolin-1
induced in activated microglia by KA is phosphory-
lated or not, because an increase in phosphorylation
of caveolin-1 has been reported in microglia in rat
spinal cord in some experimental conditions [8, 9, 22].
In addition, the apparent alterations in the expres-
sion level of caveolin-1 should be clarified by further
quantitative analysis. Future studies are needed to
address these issues.
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